Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women

Clinica Chimica Acta

Volumn 398, Issue 1-2, 2008, Pages 5-9

  Márquez, José Luis ^a,b   Pacheco, Alejandro ^a   Valdés, Patricio ^a   Salazar, Luis A ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSIDAD CATÓLICA DEL MAULE   (Chile)

Author keywords

Calpain 10; Polycystic ovary syndrome; Polymorphism; SNP 43

Indexed keywords

CALPAIN 10; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; ALLELES; BLOOD GLUCOSE; CALPAIN; CHILE; CHOLESTEROL; CHOLESTEROL, LDL; DNA; FEMALE; GENE FREQUENCY; GLUCOSE TOLERANCE TEST; HORMONES; HUMANS; INSULIN; LIPIDS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; URIC ACID; YOUNG ADULT;

EID: 54349105612     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.028     Document Type: Article

References (35)

1. Norman R.J., Dewailly D., Legro R.S., and Hickey T.E. Polycystic ovary syndrome. Lancet 370 (2007) 685-697
2. Amato P., and Simpson J.L. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18 (2004) 707-718
3. Carmina E. Genetic and environmental aspect of polycystic ovary syndrome. J Endocrinol Invest 26 (2003) 1151-1159
4. Diamanti-Kandarakis E., and Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Updat 11 (2005) 631-643
5. Vollmert C., Hahn S., Lamina C., et al. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am J Physiol Endocrinol Metabol 292 (2007) E836-E844
6. Horikawa Y., Oda N., Cox N.J., et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26 (2000) 163-175
7. Ehrmann D.A., Schwarz P.E., Hara M., et al. Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 1669-1673
8. Escobar-Morreale H.F., Peral B., Villuendas G., Calvo R.M., Sancho J., and San Millan J.L. Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil Steril 77 (2002) 581-587
9. González A., Abril E., Roca A., et al. CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 3971-3976
10. Haddad L., Evans J.C., Gharani N., et al. Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 2606-2610
11. González A., Abril E., Roca A., et al. Specific CAPN10 haplotypes influence the clinical profile of polycystic ovary patients. J Clin Endocrinol Metab 88 (2003) 5529-5536
12. Wiltgen D., Furtado L., Kohek M.B., and Spritzer P.M. CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome. Gynecol Endocrinol 23 (2007) 173-178
13. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G.R. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Cambridge, UK 377-384
14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
16. Salazar L.A., Hirata M., Cavalli S., Machado M.O., and Hirata R.D.C. Optimized procedure DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 44 (1998) 1748-1750
17. Shima Y., Nakanishi K., Odawara M., Kobayashi T., and Ohta H. Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin Chim Acta 336 (2003) 89-96
18. Orho-Melander M., Klannemark M., Svensson M.K., Ridderstrale M., Lindgren C.M., and Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51 (2002) 2658-2664
19. Crosignani P.G., and Nicolosi A.E. Polycystic ovarian disease: heritability and heterogeneity. Hum Reprod Updat 7 (2001) 3-7
20. Sampson M., Kong C., Patel A., Unwin R., and Jacobs H.S. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and the polycystic ovary syndrome. Clin Endocrinol 45 (1996) 623-629
21. Robinson S., Henderson A.D., Gelding S.V., et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol 44 (1996) 277-284
22. Meirow D., Raz I., Yossepowitch O., et al. Dyslipidaemia in polycystic ovary syndrome: different groups, different aetiologies?. Hum Reprod 11 (1996) 1848-1853
23. Cussons A.J., Stuckey B.G., and Watts G.F. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 185 (2006) 227-239
24. Cussons A.J., Stuckey B.G., and Watts G.F. Metabolic syndrome and cardiometabolic risk in PCOS. Curr Diab Rep 7 (2007) 66-73
25. Macut D., Panidis D., Glisić B., et al. Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharm 86 (2008) 199-204
26. Bhattacharya S.M. Abnormal glucose tolerance in polycystic ovary syndrome. J Obstet Gynaecol Res 34 (2008) 228-232
27. Kang E.S., Kim H.J., Nam M., et al. A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes. J Hum Genet 51 (2006) 629-633
28. Kang E.S., Nam M., Kim H.J., et al. Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract 73 (2006) 268-275
29. Cassell P.G., Jackson A.E., North B.V., et al. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51 (2002) 1622-1628
30. Song Y., Niu T., Manson J.E., Kwiatkowski D.J., and Liu S. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 74 (2004) 208-222
31. Song Y., You N.C., Hsu Y.H., et al. Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women. Hum Mol Genet 16 (2007) 2960-2971
32. Kifagi C., Makni K., Mnif F., et al. Association of calpain-10 polymorphisms with type 2 diabetes in the Tunisian population. Diabetes Metab (2008 May 16) [Electronic publication ahead of print]
33. Daimon M., Oizumi T., Saitoh T., et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 56 (2002) 147-152
34. González A., Abril E., Roca A., et al. Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients. J Clin Endocrinol Metab 88 (2003) 5529-5536
35. Carlsson E., Fredriksson J., Groop L., and Ridderstråle M. Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J Clin Endocrinol Metab 89 (2004) 3601-3605